David Lichter, MD
Neurology · Williamsville, NYNPI 1265408934
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $101,741 of the $121,001 with a category attached, or 84.1%. Teva Pharmaceuticals USA, Inc. accounts for 61.2% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $48,282 and has fallen 99.8% since, to $116 in 2025. Among neurology clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 99 payments — averaging $1222.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teva Pharmaceuticals USA, Inc.$74K
- Acorda Therapeutics, Inc$29K
- Kyowa Kirin, Inc.$15K
- Amneal Pharmaceuticals LLC$3K
- MDD US Operations, LLC$97
- Abbott$82
- plus $149 from 8 others
What the payments were for
- Consulting fees$9,5638%
- Speaking & faculty fees$101,74184%
- Travel & lodging$6,8826%
- Food & beverage$2,8162%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 47 | $74,046 |
| Acorda Therapeutics, Inc | 23 | $29,125 |
| Kyowa Kirin, Inc. | 10 | $14,802 |
| Amneal Pharmaceuticals LLC | 3 | $2,700 |
| MDD US Operations, LLC | 4 | $97 |
| Abbott | 4 | $82 |
| Medtronic | 1 | $29 |
| Eisai Inc. | 1 | $24 |
| Amgen | 1 | $20 |
| AbbVie | 1 | $18 |
| Almatica Pharma LLC | 1 | $16 |
| Sunovion Pharmaceuticals Inc. | 1 | $16 |
| Impel Pharmaceuticals Inc. | 1 | $15 |
| Lundbeck LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$69,916
- INBRIJA$28,646
- NOURIANZ$14,781
- Austedo XR$3,616
- RYTARY$2,700
How this compares
$121,001 in reported general payments places this provider in the 90th percentile of 1,623 neurology providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Rasagiline Mesylate | 85 | $23,899 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 212 | $15,178 |
| Entacapone | 43 | $8,596 |
| Carbidopa-Levodopa ErCarbidopa/Levodopa | 105 | $5,555 |
| Pramipexole ErPramipexole Di-Hcl | 13 | $4,607 |
| Selegiline Hcl | 24 | $4,446 |
| AmantadineAmantadine Hcl | 45 | $2,294 |
| Primidone | 53 | $2,066 |
| Pramipexole DihydrochloridePramipexole Di-Hcl | 52 | $2,056 |
| Gabapentin | 55 | $1,211 |
| Quetiapine Fumarate | 26 | $1,170 |
| Midodrine Hcl | 11 | $613 |
| Donepezil Hcl | 30 | $553 |
| Propranolol Hcl | 17 | $326 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 11 | $245 |
Paid to pharmacies, not to this prescriber.
Other neurology in Williamsville
- Kenneth HalliwellWilliamsville$200K
- Idan SharonBrooklyn$2.1M
- Allan PerelStaten Island$1.7M
- Nicolas SaikaliAmherst$1.5M
- David KreitzmanCommack$1.5M
- Charles ArgoffAlbany$1.2M
- Stephen KriegerNew York$1.1M
- Robert FeketeHawthorne$1M
- Jennifer McVigeAmherst$982K
- Warren SpinnerPort Jefferson Station$791K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.